Phase III trial of bevacizumab plus interferon alfa versus interferon alfa monotherapy in patients with metastatic renal cell carcinoma: final results of CALGB 90206 - Rini, B I; Halabi, S; Rosenberg, J E (J Clin Oncol, 2010)
et al.